Close Menu

NEW YORK (360Dx) — Antibodies to human papillomavirus type 16 (HPV16) can be detected in the blood up to 28 years before diagnosis of throat cancer caused by the virus, indicating that they potentially could serve as a new biomarker for identifying people at high risk for the malignancy, according to a new study released today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients. 

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.